Catherine Moukheibir
Director/Board Member bij MOONLAKE IMMUNOTHERAPEUTICS
Vermogen: 1 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Catherine Moukheibir
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
225
| Public Company | Investment Managers | 225 |
Salomon Smith Barney, Inc.
53
| Extinct | Investment Banks/Brokers | 53 |
| Public Company | Pharmaceuticals: Major | 35 | |
| Public Company | Biotechnology | 24 | |
| Public Company | Pharmaceuticals: Major | 22 | |
19
| Subsidiary | Biotechnology | 19 |
19
| Public Company | Chemicals: Agricultural | 19 |
| Public Company | Pharmaceuticals: Major | 15 | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland.
15
| Holding Company | Pharmaceuticals: Major | 15 |
DNA Script SAS
 DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France.
14
| Holding Company | Medical Specialties | 14 |
| Public Company | Pharmaceuticals: Major | 11 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
CMR Surgical Ltd.
 CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom.
9
| Holding Company | Medical Specialties | 9 |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland.
8
| Holding Company | Biotechnology | 8 |
| Extinct | Biotechnology | 7 | |
Creabilis Holdings Ltd.
 Creabilis Holdings Ltd. Pharmaceuticals: MajorHealth Technology Creabilis Holdings Ltd. operates as a biotechnology company. The company was founded on June 7, 2013 and is headquartered in Canterbury, the United Kingdom.
7
| Extinct | Pharmaceuticals: Major | 7 |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France.
6
| Holding Company | Biotechnology | 6 |
| Subsidiary | Pharmaceuticals: Major | 6 | |
STJ Advisors LLP
 STJ Advisors LLP Investment ManagersFinance STJ Advisors LLP provides capital markets advisory services. The private company is based in London, UK and has subsidiaries in Hong Kong. The British company was founded in 2008 by John James Moore St. John.
2
| Private Company | Investment Managers | 2 |
| Public Company | Pharmaceuticals: Major | 2 | |
Movetis NV
 Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium.
1
| Extinct | Pharmaceuticals: Generic | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Catherine Moukheibir via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Chief Executive Officer President | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member General Counsel | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
McNeil Consumer Healthcare (Canada)
 McNeil Consumer Healthcare (Canada) Household/Personal CareConsumer Non-Durables McNeil Consumer Healthcare manufactures medicals products. It offers headache and muscle pain, arthritis pain, sinus, cold, flu, sleep and pain products as well as products for children and infants. The company is headquartered in Guelph, Canada. | Household/Personal Care | President President | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| MEDIGENE AG | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chairman Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Chairman Private Equity Investor Private Equity Investor | |
| University of Cambridge | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| Yale University | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Doctorate Degree Corporate Officer/Principal | |
| Wesleyan University | College/University | Director/Board Member Undergraduate Degree | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Corporate Officer/Principal Investor Relations Contact | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Leiden | College/University | Undergraduate Degree Doctorate Degree | |
| University of Groningen | College/University | Doctorate Degree Undergraduate Degree | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Oxford Biomedica (UK) Ltd.
 Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxford Biomedica (UK) Ltd. is a viral vector contract development and manufacturing organization (CDMO) based in Oxford, UK. Oxford Biomedica (UK has over 25 years of experience in the industry and is committed to enabling its clients to deliver life-changing therapies to patients worldwide. The British company offers innovative solutions to cell and gene therapy biotechnology and biopharma companies by working across key viral vector delivery systems including adeno-associated virus (AAV) and lentiviral delivery system. | Biotechnology | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Director/Board Member Director/Board Member | |
| CYCLERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member President | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin Masters Business Admin | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| INVIVYD, INC. | Biotechnology | Director/Board Member Chief Operating Officer |
Statistieken
Internationaal
| Verenigde Staten | 26 |
| Verenigd Koninkrijk | 7 |
| Zweden | 6 |
| Nederland | 4 |
| Zwitserland | 4 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 680 |
| Corporate Officer/Principal | 213 |
| Independent Dir/Board Member | 190 |
| Chairman | 118 |
| Chief Executive Officer | 91 |
Sterkste connecties
| Insiders | |
|---|---|
| Terry McGuire | 51 |
| Antoine Papiernik | 48 |
| Amy Schulman | 45 |
| Michael Carpenter | 42 |
| Tony Vernon | 34 |
| Heather Elizabeth Preston | 34 |
| Bo Jesper Hansen | 34 |
| Alf Gunnar Martin Nicklasson | 31 |
| Jay Shepard | 30 |
| Patrick van Beneden | 28 |
| Jeffrey Berkowitz | 26 |
| Julie McHugh | 26 |
| Alexander Denner | 25 |
| Mike Gutch | 24 |
| Andrew Phillips | 23 |
- Beurs
- Insiders
- Catherine Moukheibir
- Bedrijfsconnecties
